nach oben

Zeitschrift für Rheumatologie

Erschienen in:

01.04.2015 | Originalien

Meta-analysis of genetic polymorphisms in programmed cell death 1

Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility

verfasst von: Y.H. Lee, MD, PhD, S.-C. Bae, J.-H. Kim, G.G. Song

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to determine whether genetic polymorphisms in programmed cell death 1 (PDCD1 or PD1) are associated with susceptibility to rheumatoid arthritis (RA), ankylosing spondylitis (AS), and type 1 diabetes (T1D).

Methods

We conducted a meta-analysis to investigate the association between PDCD1 polymorphisms and RA, AS, and T1D in the overall population and in specific ethnic populations.

Results

Sixteen studies, comprising 13,210 patients and 17,073 controls, were conducted for the meta-analysis including 4 studies on RA, 4 on AS, and 8 on T1D. The meta-analysis showed an association between RA and the 2 alleles of the PD1.3 polymorphism in the overall population [odds ratio (OR) 1.183, 95 % confidence interval (95 % CI) 1.005–1.392, p = 0.043]. However, meta-analysis showed no association between RA and the 2 alleles of the PD1.1 and PD1.5 polymorphisms in the overall population. Meta-analysis identified an association between AS and the 2 alleles of the PD1.5 and PD1.9 polymorphisms in the Asian population (OR 1.251, 95 % CI 1.019–1.535, p = 0.033; OR 1.975, 95 % CI 1.286–3.034, p = 0.002, respectively). The meta-analysis revealed a significant association between T1D and the 2 alleles of the PD1.3 polymorphism in the European population (OR 1.098, 95 % CI 1.029–1.171, p = 0.005). The meta-analysis showed an association between the PD1.5 polymorphism and T1D in Asians (OR 1.332, 95 % CI 1.067–1.663, p = 0.011) and between the PD1.9 polymorphism and T1D in the Asian population (OR 1.363, 95 % CI 1.107–1.679, p = 0.004).

Conclusion

The meta-analysis suggests an association between the PD1.3 polymorphism and RA in the overall population and an association between the PD1.5 and PD1.9 polymorphisms, and AS in the Asian population. Furthermore, the PD1.3 , 5, and 9 polymorphisms were associated with T1D susceptibility in Europeans, or Asians.

Lee YH, Rho YH, Choi SJ et al (2005) Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 50:453–459CrossRefPubMed

Choi SJ, Rho YH, Ji JD et al (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45:166–170

Lee YH, Rho YH, Choi SJ et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology (Oxford) 46:49–56

Okazaki T, Wang J (2005) PD-1/PD-L pathway and autoimmunity. Autoimmunity 38:353–357CrossRefPubMed

Nishimura H, Minato N, Nakano T, Honjo T (1998) Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 10:1563–1572CrossRefPubMed

Prokunina L, Castillejo-Lopez C, Oberg F et al (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32:666–669CrossRefPubMed

Tahoori MT, Pourfathollah AA, Akhlaghi M et al (2011) Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients. Clin Exp Rheumatol 29:763–767PubMed

Iwamoto T, Ikari K, Inoue E et al (2007) Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population. J Hum Genet 52:557–560CrossRefPubMed

Kong EK, Prokunina-Olsson L, Wong WH et al (2005) A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 52:1058–1062CrossRefPubMed

10.

Prokunina L, Padyukov L, Bennet A et al (2004) Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 50:1770–1773CrossRefPubMed

11.

Yang Q, Liu Y, Liu D et al (2011) Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population. Clin Exp Rheumatol 29:13–18PubMed

12.

Soleimanifar N, Amirzargar AA, Mahmoudi M et al (2011) Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis. Inflammation 34:707–712CrossRefPubMed

13.

Liu X, Hu LH, Li YR et al (2011) Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population. Rheumatol Int 31:209–213CrossRefPubMed

14.

Lee SH, Lee YA, Woo DH et al (2006) Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res Ther 8:R163CrossRefPubMedCentralPubMed

15.

Flores S, Beems M, Oyarzun A et al (2010) Programmed cell death 1 (PDCD1) gene polymorphisms and type 1 diabetes in Chilean children. Rev Med Chil 138:543–550CrossRefPubMed

16.

Fichna M, Zurawek M, Januszkiewicz-Lewandowska D et al (2010) Association of the CYP27B1C(-1260)A polymorphism with autoimmune Addison’s disease. Exp Clin Endocrinol Diabetes 118:544–549CrossRefPubMed

17.

Momin S, Flores S, Angel BB et al (2009) Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes. Diabetes Res Clin Pract 83:289–294CrossRefPubMed

18.

Cooper JD, Smyth DJ, Bailey R et al (2007) The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet 8:71CrossRefPubMedCentralPubMed

19.

Hiromine Y, Ikegami H, Fujisawa T et al (2007) Trinucleotide repeats of programmed cell death-1 gene are associated with susceptibility to type 1 diabetes mellitus. Metabolism 56:905–909CrossRefPubMed

20.

Ni R, Ihara K, Miyako K et al (2007) PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children. Hum Genet 121:223–232CrossRefPubMed

21.

Nielsen C, Hansen D, Husby S et al (2003) Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62:492–497CrossRefPubMed

22.

Asad S, Nikamo P, Torn C et al (2007) No evidence of association of the PDCD1 gene with Type 1 diabetes. Diabet Med 24:1473–1477CrossRefPubMed

23.

Nath SK, Harley JB, Lee YH (2005) Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 118:225–234CrossRefPubMed

24.

Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter −308A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364–371CrossRefPubMed

25.

Song GG, Bae SC, Lee YH (2012) Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 31:1733–1739CrossRefPubMed

26.

Davey Smith G, Egger M (1997) Meta-analyses of randomised controlled trials. Lancet 350:1182

27.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefPubMed

28.

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed

29.

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634CrossRefPubMedCentralPubMed

30.

Lee YH, Woo JH, Choi SJ et al (2009) Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus 18:9–15CrossRefPubMed

31.

Marrack P, Kappler J, Kotzin BL (2001) Autoimmune disease: why and where it occurs. Nat Med 7:899–905CrossRefPubMed

32.

Becker KG (2004) The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62:309–317CrossRefPubMed

33.

Krishnan S, Chowdhury B, Tsokos GC (2006) Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 18:230–243CrossRefPubMed

34.

Kang BR, Kim H, Nam SH et al (2012) CopA3 peptide from Copris tripartitus induces apoptosis in human leukemia cells via a caspase-independent pathway. BMB Rep 45:85–90CrossRefPubMed

35.

Hiromine Y, Ikegami H, Fujisawa T et al (2006) Molecular scanning of the gene for programmed cell death-1 (PDCD-1) as a candidate for type 1 diabetes susceptibility. Ann N Y Acad Sci 1079:285–288CrossRefPubMed

36.

Mori M, Yamada R, Kobayashi K et al (2005) Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50:264–266CrossRefPubMed

Titel: Meta-analysis of genetic polymorphisms in programmed cell death 1
Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility
verfasst von: Y.H. Lee, MD, PhD
S.-C. Bae
J.-H. Kim
G.G. Song
Publikationsdatum: 01.04.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Zeitschrift für Rheumatologie / Ausgabe 3/2015
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI: https://doi.org/10.1007/s00393-014-1415-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Pathogenese des systemischen Lupus erythematodes

Lupustherapie in Bewegung

Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis

Antiphospholipid-Syndrom

Erratum zu: Rezidivierende Polychondritis. Primär- und Verlaufsdiagnostik mittels 18F-FDG-PET/CT